Kyle Brown

Dr. Kyle Brown

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Critical Care Nurse
Verified
Journal Article
Closed access
PDF file
CTCalvin Tucker
Calvin Tucker
LTLyn Tucker
Lyn Tucker
KBKyle Brown
Kyle Brown
Intranasal drug administration is a less invasive method of drug delivery that is easily accessible for adult and pediatric patients. Medications administered by the intranasal route have efficacy comparable to intravenous administration and typically have superior efficacy to subcutaneous or intramuscular routes. The intranasal route is beneficial in emergent situations when the intravenous route is not available. The intranasal route is safe and effective in various indications, and therapeutic systemic concentrations of medication can be attained via this route. As the evidence for and comfort with intranasal administration continue to grow, guidance on correct technique, medications, and dosing is vital for appropriate use. This article reviews the process and practices of appropriate intranasal medication administration.

12 June 2022 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
ALAna-Alicia Leonso
Ana-Alicia Leonso
KBKyle Brown
Kyle Brown
RPRaquel Prol
Raquel Prol
SRSaumya Rawat
Saumya Rawat
AKArjun Khunger
Arjun Khunger
RBRomina Bromberg
Romina Bromberg
Coronavirus disease 2019 (COVID-19) and tuberculosis (TB) are currently the two leading causes of death among infectious diseases. As we progress towards a “new normal”, more information is required regarding post-COVID-19 syndromes. We present a case of latent tuberculosis reactivation 3 months after a successful inpatient treatment of COVID-19. A 74-year-old female from the Philippines presented with a new left mid-lung infiltrate with worsening shortness of breath and lethargy for one week prior to admission. The clinical course of the patient deteriorated despite broad-spectrum antibiotics, diuretics, and high-dose steroid therapy requiring intubation and mechanical ventilation. Her sputum culture yielded the microbiological diagnosis of TB. Anti-tubercular medications were started and the patient had a favorable clinical outcome. Our case demonstrates that immunosuppression secondary to COVID-19 and its treatments may promote the development of an active TB infection from a latent infection. It is important to be aware of this potential increase in risk during and after a COVID-19 treatment. This is especially important in high-risk populations to ensure an early diagnosis and prompt management as well as to reduce transmission.

1 October 2020 in Critical Care Nurse
Verified
Journal Article
Open access
PDF file
KBKyle Brown
Kyle Brown
CTCalvin Tucker
Calvin Tucker
Ketamine is beneficial in clinical settings ranging from procedural sedation to the treatment of chronic pain. This article describes the clinical benefits of ketamine for treatment of acute pain and for sedation of patients undergoing mechanical ventilation. Ketamine causes analgesic and amnestic effects by noncompetitive inhibition of the N-methyl-D-aspartate receptor and activation of the opioid μ and κ receptors. Unlike other sedatives, ketamine provides analgesia and amnesia without causing hypotension or respiratory depression. Several studies have elucidated the clinical benefits of ketamine. The use of ketamine has extended beyond critical care areas such as the operating room and intensive care units. Nurses must be familiar with optimal clinical scenarios, monitoring parameters, and contraindications of ketamine. To highlight the clinical utility and pharmacological properties of ketamine through a literature review. Current studies of ketamine in acute pain and sedation management are summarized. This narrative review describes pharmacological properties, dosing strategies, adminis­tration considerations, and adverse effects of ketamine.

11 June 2020 in Pharmacy
Verified
Journal Article
Open access
PDF file
VHVanessa Huffman
Vanessa Huffman
DADiana Carolina Andrade
Diana Carolina Andrade
JHJared Ham
Jared Ham
KBKyle Brown
Kyle Brown
LMLeonid Melnitsky
Leonid Melnitsky
JPJayesh Parmar
Jayesh Parmar
Methicillin-resistant Staphylococcus aureus (MRSA) polymerase-chain-reaction nasal swabs (PCRNS) are a rapid diagnostic tool with a high negative predictive value. A PCRNS plus education “bundle” was implemented to inform clinicians on the utility of PCRNS for anti-MRSA therapy de-escalation in respiratory tract infections (RTI). The study included patients started on vancomycin with a PCRNS order three months before and after bundle implementation. The primary objective was the difference in duration of anti-MRSA therapy (DOT) for RTI. Secondary objectives included hospital length of stay (LOS), anti-MRSA therapy reinitiation, 30-day readmission, in-hospital mortality, and cost. We analyzed 62 of 110 patients screened, 20 in the preintervention and 42 in the postintervention arms. Mean DOT decreased after bundle implementation by 30.3 h (p = 0.039); mean DOT for patients with a negative PCRNS decreased by 39.7 h (p = 0.014). Median cost was lower after intervention [USD$51.69 versus USD$75.30 (p < 0.01)]. No significant difference in LOS, mortality, or readmission existed. The bundle implementation decreased vancomycin therapy and cost without negatively impacting patient outcomes.

21 November 2022 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
OAOsama Assad
Osama Assad
RZRolando Zamora
Rolando Zamora
KBKyle Brown
Kyle Brown
LMLeon Melnitsky
Leon Melnitsky
JMJessica Moses
Jessica Moses
VSVeronica Sherman
Veronica Sherman

1 September 2026 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
AAAli A. Althubyani
Ali A. Althubyani
BLBenito Fernandez Lopez
Benito Fernandez Lopez
LFLily G. Fechtmeyer
Lily G. Fechtmeyer
DSDaria K. Szczepanek
Daria K. Szczepanek
MCMelissa A. Catalano
Melissa A. Catalano
DHDana Holger
Dana Holger